Gut Microbiota Influences Survival After Pediatric Stem Cell Transplant
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 16, 2023 -- For pediatric patients, gut microbiota diversity and composition before allogeneic hematopoietic stem cell transplantation (allo-HSCT) influences survival and likelihood of acute graft-versus-host disease, according to a study published online Aug. 10 in Blood.
Noting that there is an association between gut microbiota diversity and survival after allo-HSCT in adults, Riccardo Masetti, M.D., Ph.D., from the University of Bologna in Italy, and colleagues analyzed stool samples from a multicenter cohort of 90 pediatric allo-HSCT recipients using 16S rRNA amplicon sequencing to profile the gut microbiota and estimate diversity. The ecological structure of the gut microbiota was characterized; patients were stratified into higher- and lower-diversity groups pretransplantation and at neutrophil engraftment.
The researchers found that the group with higher diversity prior to transplantation had a higher probability of overall survival and lower incidence of grade II to IV and III to IV acute graft-versus-host disease. The two groups had no significant difference in relapse-free survival. Higher relative abundance of potentially health-related families, such as Ruminococcaceae and Oscillospiraceae, characterized the higher-diversity group. An overabundance of Enterococcaceae and Enterobacteriaceae was seen in the lower-diversity group. In the higher-diversity group, short-chain fatty acid producers such as Blautia, Faecalibacterium, Roseburia, and Bacteroides were keystones, whereas in the lower-diversity group, Enterococcus, Escherichia-Shigella, and Enterobacter were the keystones.
"Our study provides the first evidence of a relationship between pretransplant microbial diversity in the intestinal tract and post-transplant survival in children," Masetti said in a statement. "This finding suggests that interventions to improve microbial diversity before transplantation could help more children survive."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Persistent Sociodemographic Differences Seen in Use of AutoHCT for Multiple Myeloma
WEDNESDAY, May 8, 2024 -- Sociodemographic differences persist in utilization of autologous hematopoietic cell transplantation (autoHCT) for multiple myeloma, according to a study...
Hematopoietic Cell Transplantation Use Has Increased for All Racial Groups
MONDAY, May 6, 2024 -- Hematopoietic cell transplantation (HCT) use has increased among all racial/ethnic groups and has increased faster among non-Hispanic African Americans...
Improvements Seen in Post-Allo-HCT Outcomes for Seniors With Leukemia
THURSDAY, March 28, 2024 -- For older patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic cell transplantation (allo-HCT), posttransplant outcomes have...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.